Literature DB >> 1382920

Visuospatial judgment and right hemisphere disease.

K Hamsher1, D X Capruso, A Benton.   

Abstract

The performances of patients with stroke-produced unilateral hemispheric lesions on a test requiring the identification of lines were examined in the light of a recent report that contradicted previous observations. The study confirmed the results of earlier studies that patients with lesions of the right hemisphere show a remarkably high frequency of defective performances while those with lesions of the left hemisphere do not. Possible reasons for findings that deviate from this rule are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1382920     DOI: 10.1016/s0010-9452(13)80157-8

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  4 in total

1.  Hemispheric preference in visuospatial processing: a complementary approach with fMRI and lesion studies.

Authors:  V W Ng; P J Eslinger; S C Williams; M J Brammer; E T Bullmore; C M Andrew; J Suckling; R G Morris; A L Benton
Journal:  Hum Brain Mapp       Date:  2000-06       Impact factor: 5.038

2.  Neuroanatomical correlates of the Benton Facial Recognition Test and Judgment of Line Orientation Test.

Authors:  Daniel Tranel; Eduardo Vianna; Kenneth Manzel; Hanna Damasio; Thomas Grabowski
Journal:  J Clin Exp Neuropsychol       Date:  2009-02       Impact factor: 2.475

3.  The relationship between neuropsychological tests of visuospatial function and lobar cortical thickness.

Authors:  Davor N Zink; Justin B Miller; Jessica Z K Caldwell; Christopher Bird; Sarah J Banks
Journal:  J Clin Exp Neuropsychol       Date:  2017-11-07       Impact factor: 2.475

4.  Visuospatial performance in patients with statistically-defined mild cognitive impairment.

Authors:  Victor Wasserman; Sheina Emrani; Emily F Matusz; Jamie Peven; Seana Cleary; Catherine C Price; Terrie Beth Ginsberg; Rodney Swenson; Kenneth M Heilman; Melissa Lamar; David J Libon
Journal:  J Clin Exp Neuropsychol       Date:  2020-01-24       Impact factor: 2.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.